Quercetin Attenuates Atherosclerosis

ApoE-/- mice atherosclerosis endothelial cellular senescence oxidized low-density lipoprotein quercetin

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2020
Historique:
received: 16 10 2019
accepted: 31 03 2020
entrez: 16 5 2020
pubmed: 16 5 2020
medline: 16 5 2020
Statut: epublish

Résumé

Endothelial senescence is an important risk factor leading to atherosclerosis. The mechanism of quercetin against endothelial senescence is worth exploring. Quercetin (20 mg/kg/d) was administered to ApoE ApoE Quercetin alleviated atherosclerotic lesion both

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Endothelial senescence is an important risk factor leading to atherosclerosis. The mechanism of quercetin against endothelial senescence is worth exploring.
METHODS METHODS
Quercetin (20 mg/kg/d) was administered to ApoE
RESULTS RESULTS
ApoE
CONCLUSIONS CONCLUSIONS
Quercetin alleviated atherosclerotic lesion both

Identifiants

pubmed: 32410992
doi: 10.3389/fphar.2020.00512
pmc: PMC7198817
doi:

Types de publication

Journal Article

Langues

eng

Pagination

512

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2020 Jiang, Jiang, Wang, Ma and Li.

Références

Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
Oncotarget. 2017 Jun 13;8(24):38631-38641
pubmed: 28418847
Exp Ther Med. 2019 Oct;18(4):2451-2458
pubmed: 31555357
Aging Cell. 2009 Jun;8(3):226-38
pubmed: 19245678
Mech Ageing Dev. 2015 Nov;151:101-13
pubmed: 25804383
Cell Immunol. 2016 Dec;310:131-140
pubmed: 27585526
Nat Rev Mol Cell Biol. 2007 Sep;8(9):729-40
pubmed: 17667954
Int J Mol Med. 2019 Sep;44(3):893-902
pubmed: 31524223
Biochem Pharmacol. 2017 Sep 1;139:15-23
pubmed: 28377278
J Am Geriatr Soc. 2017 Oct;65(10):2297-2301
pubmed: 28869295
Oxid Med Cell Longev. 2016;2016:2986796
pubmed: 26904161
Mol Cells. 2017 Jul 31;40(7):503-514
pubmed: 28736426
Expert Opin Ther Targets. 2007 Dec;11(12):1623-37
pubmed: 18020982
Aging Cell. 2016 Oct;15(5):973-7
pubmed: 26864908
Circulation. 2015 Nov 17;132(20):1909-19
pubmed: 26416809
Hum Mol Genet. 2010 Aug 1;19(15):3089-101
pubmed: 20484221
Aging Cell. 2015 Aug;14(4):644-58
pubmed: 25754370
Biomed Pharmacother. 2017 Jan;85:658-671
pubmed: 27919735
Aging Cell. 2006 Oct;5(5):413-22
pubmed: 16939484
Oxid Med Cell Longev. 2018 Oct 28;2018:5073420
pubmed: 30510622
Front Physiol. 2012 May 28;3:132
pubmed: 22783194
Circulation. 2002 Apr 2;105(13):1541-4
pubmed: 11927518
Circulation. 2002 Aug 20;106(8):939-44
pubmed: 12186797
Cell Metab. 2019 May 7;29(5):1061-1077.e8
pubmed: 30612898
Eur J Med Chem. 2019 Aug 15;176:68-91
pubmed: 31096120
Nat Rev Mol Cell Biol. 2014 Jul;15(7):482-96
pubmed: 24954210
J Physiol. 2016 Apr 15;594(8):2115-24
pubmed: 26174609

Auteurs

Yue-Hua Jiang (YH)

Central Laboratory, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.

Ling-Yu Jiang (LY)

Cardiovascular Department, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.

Yong-Cheng Wang (YC)

Cardiovascular Department, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.

Du-Fang Ma (DF)

Cardiovascular Department, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.

Xiao Li (X)

Cardiovascular Department, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.

Classifications MeSH